HRP20200844T1 - Heterociklički spoj i njegova uporaba kao pozitivnog alosteričnog modulatora ampa-receptora - Google Patents

Heterociklički spoj i njegova uporaba kao pozitivnog alosteričnog modulatora ampa-receptora Download PDF

Info

Publication number
HRP20200844T1
HRP20200844T1 HRP20200844TT HRP20200844T HRP20200844T1 HR P20200844 T1 HRP20200844 T1 HR P20200844T1 HR P20200844T T HRP20200844T T HR P20200844TT HR P20200844 T HRP20200844 T HR P20200844T HR P20200844 T1 HRP20200844 T1 HR P20200844T1
Authority
HR
Croatia
Prior art keywords
optionally substituted
halogen atom
alkyl
phenyl
substituted
Prior art date
Application number
HRP20200844TT
Other languages
English (en)
Croatian (hr)
Inventor
Masakuni Kori
Toshihiro Imaeda
Shinji Nakamura
Masashi Toyofuku
Eiji Honda
Yasutomi Asano
Osamu Ujikawa
Michiyo Mochizuki
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Publication of HRP20200844T1 publication Critical patent/HRP20200844T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HRP20200844TT 2010-08-10 2011-08-09 Heterociklički spoj i njegova uporaba kao pozitivnog alosteričnog modulatora ampa-receptora HRP20200844T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10
PCT/JP2011/068497 WO2012020848A1 (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof
EP11749944.2A EP2603513B1 (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof as ampa receptor positive allosteric modulator

Publications (1)

Publication Number Publication Date
HRP20200844T1 true HRP20200844T1 (hr) 2020-08-21

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20200844TT HRP20200844T1 (hr) 2010-08-10 2011-08-09 Heterociklički spoj i njegova uporaba kao pozitivnog alosteričnog modulatora ampa-receptora

Country Status (39)

Country Link
US (11) US8575154B2 (enExample)
EP (1) EP2603513B1 (enExample)
JP (2) JP5788496B2 (enExample)
KR (1) KR101852215B1 (enExample)
CN (2) CN103180326B (enExample)
AR (1) AR082618A1 (enExample)
AU (1) AU2011290126B2 (enExample)
BR (1) BR112013002250B1 (enExample)
CA (1) CA2807460C (enExample)
CL (1) CL2013000380A1 (enExample)
CO (1) CO6680700A2 (enExample)
CR (1) CR20130066A (enExample)
CY (1) CY1123507T1 (enExample)
DK (1) DK2603513T3 (enExample)
DO (1) DOP2013000030A (enExample)
EA (1) EA022078B1 (enExample)
EC (1) ECSP13012478A (enExample)
ES (1) ES2793723T3 (enExample)
GE (1) GEP20156216B (enExample)
HR (1) HRP20200844T1 (enExample)
HU (1) HUE049460T2 (enExample)
IL (1) IL224452A (enExample)
LT (1) LT2603513T (enExample)
MA (1) MA34509B1 (enExample)
MX (1) MX349470B (enExample)
MY (1) MY165908A (enExample)
NZ (1) NZ607593A (enExample)
PE (1) PE20131116A1 (enExample)
PH (1) PH12013500247A1 (enExample)
PL (1) PL2603513T3 (enExample)
PT (1) PT2603513T (enExample)
RS (1) RS60311B1 (enExample)
SG (1) SG187656A1 (enExample)
SI (1) SI2603513T1 (enExample)
TW (1) TWI504604B (enExample)
UA (1) UA111594C2 (enExample)
UY (1) UY33551A (enExample)
WO (1) WO2012020848A1 (enExample)
ZA (1) ZA201301120B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2603513B1 (en) * 2010-08-10 2020-03-11 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof as ampa receptor positive allosteric modulator
US9527807B2 (en) 2011-04-05 2016-12-27 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
EP2813508B1 (en) * 2012-02-08 2018-01-31 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
JP2016521755A (ja) * 2013-06-13 2016-07-25 ヴェロサイエンス,リミテッド・ライアビリティー・カンパニー 代謝障害を治療するための組成物および方法
PT3013813T (pt) 2013-06-27 2019-06-14 Pfizer Compostos heteroaromáticos e a sua utilização como ligandos de d1 de dopamina
AU2014357342B2 (en) 2013-12-03 2019-01-17 Fmc Corporation Pyrrolidinones as herbicides
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
PE20170444A1 (es) 2014-07-02 2017-05-11 Du Pont Herbicidas de piperidinona
AU2015361018B2 (en) 2014-12-08 2020-01-16 Fmc Corporation 3-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones
JP6956637B2 (ja) 2015-04-10 2021-11-02 エフ エム シー コーポレーションFmc Corporation 除草剤としての置換環状アミド
BR112017020094B1 (pt) 2015-04-27 2022-01-11 Fmc Corporation Composto, composições herbicidas, mistura de herbicida e método para controlar o crescimento de vegetação indesejada
CA2984307A1 (en) * 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
CA2983826A1 (en) * 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Azabenzimidazoles and their use as ampa receptor modulators
CA2980643C (en) 2015-05-12 2023-10-17 E I Du Pont De Nemours And Company Aryl substituted bicyclic compounds as herbicides
US10906873B2 (en) 2015-05-29 2021-02-02 Fmc Corporation Substituted cyclic amides as herbicides
CN107709310B (zh) 2015-06-02 2021-09-24 Fmc公司 取代的环酰胺及其作为除草剂的用途
RU2720994C2 (ru) 2015-07-31 2020-05-15 Е.И.Дюпон Де Немур Энд Компани Новые соединения циклического n-карбоксамида, применяемые в качестве гербицидов
HRP20191589T1 (hr) * 2015-08-06 2019-12-13 Hoffmann La Roche Postupci za pripravu derivata galnac kiseline
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
EP3558962B1 (en) 2016-12-21 2023-07-12 FMC Corporation Nitrone herbicides
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用,药物组合物
WO2018175231A1 (en) 2017-03-21 2018-09-27 Fmc Corporation Herbicidal mixture, composition and method
EP3599854A4 (en) 2017-03-21 2020-12-23 FMC Corporation PYRROLIDINONES AND PROCESS FOR PREPARING THEM
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
EP3693368B1 (en) * 2017-10-06 2023-12-06 Takeda Pharmaceutical Company Limited Heterocyclic compound
ES2971497T3 (es) 2017-10-06 2024-06-05 Takeda Pharmaceuticals Co Compuestos heterocíclicos
PH12022550597A1 (en) 2019-09-16 2024-03-04 Takeda Pharmaceuticals Co Azole-fused pyridazin-3(2h)-one derivatives
US20230338391A1 (en) * 2020-05-15 2023-10-26 Takeda Pharmaceutical Company Limited Treatment for depression
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
WO2025224508A1 (en) 2024-04-22 2025-10-30 Takeda Pharmaceutical Company Limited Pharmaceutical composition for treating depressive disorders

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (enExample) 1986-10-22 1992-09-04
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
JP2003526341A (ja) 1999-11-04 2003-09-09 コロラド ステート ユニバーシティー リサーチ ファウンデーション 昆虫を誘引するための装置および方法
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2458388A1 (en) * 2001-10-10 2003-04-17 Neurosearch A/S Novel benzothiazine derivatives, their preparation and use
FR2833955B1 (fr) 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) * 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ZA200810793B (en) 2006-06-23 2010-03-31 Nufarm Australia Ltd Phenoxy alkanoate herbicidal composition and method of preparation and use
CA2672462A1 (en) * 2006-12-11 2008-06-19 Eli Lilly And Company Ampa receptor potentiators
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
MX2010005028A (es) 2007-11-05 2010-05-27 Schering Corp Moduladores de gamma secretasa.
JP2011507910A (ja) * 2007-12-21 2011-03-10 ユニバーシティー オブ ロチェスター 真核生物の寿命を変更するための方法
US20110118236A1 (en) 2008-03-25 2011-05-19 Michiyo Mochizuki Heterocyclic compound
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) * 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
CA2742602A1 (en) 2008-11-06 2010-05-14 Schering Corporation Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
JPWO2011007756A1 (ja) 2009-07-13 2012-12-27 武田薬品工業株式会社 複素環化合物及びその用途
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
EP2603513B1 (en) * 2010-08-10 2020-03-11 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof as ampa receptor positive allosteric modulator

Also Published As

Publication number Publication date
US8778934B2 (en) 2014-07-15
US20200317692A1 (en) 2020-10-08
DOP2013000030A (es) 2013-03-15
CR20130066A (es) 2013-05-03
ES2793723T3 (es) 2020-11-16
MY165908A (en) 2018-05-18
UY33551A (es) 2012-03-30
US10654874B2 (en) 2020-05-19
TWI504604B (zh) 2015-10-21
BR112013002250A2 (pt) 2016-05-24
US20140080817A1 (en) 2014-03-20
US8575154B2 (en) 2013-11-05
HUE049460T2 (hu) 2020-09-28
JP6113789B2 (ja) 2017-04-12
CN103180326A (zh) 2013-06-26
JP2013535408A (ja) 2013-09-12
US20150353578A1 (en) 2015-12-10
US20130190291A1 (en) 2013-07-25
CN103180326B (zh) 2015-06-10
JP2016006080A (ja) 2016-01-14
CN104926837A (zh) 2015-09-23
IL224452A (en) 2017-11-30
PH12013500247A1 (en) 2013-03-11
US8916551B2 (en) 2014-12-23
DK2603513T3 (da) 2020-06-15
PE20131116A1 (es) 2013-10-24
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
US20240360156A1 (en) 2024-10-31
LT2603513T (lt) 2020-05-25
EP2603513A1 (en) 2013-06-19
ECSP13012478A (es) 2013-04-30
PL2603513T3 (pl) 2020-07-27
ZA201301120B (en) 2014-04-30
JP5788496B2 (ja) 2015-09-30
WO2012020848A1 (en) 2012-02-16
CA2807460A1 (en) 2012-02-16
GEP20156216B (en) 2015-01-12
CY1123507T1 (el) 2022-03-24
US9150591B2 (en) 2015-10-06
BR112013002250B1 (pt) 2020-10-27
RS60311B1 (sr) 2020-07-31
SG187656A1 (en) 2013-03-28
CO6680700A2 (es) 2013-05-31
EP2603513B1 (en) 2020-03-11
MX349470B (es) 2017-07-31
NZ607593A (en) 2015-01-30
CL2013000380A1 (es) 2013-05-31
US20150073137A1 (en) 2015-03-12
US9499568B2 (en) 2016-11-22
AR082618A1 (es) 2012-12-19
EA022078B1 (ru) 2015-10-30
KR101852215B1 (ko) 2018-04-25
US20130184266A1 (en) 2013-07-18
US20170022222A1 (en) 2017-01-26
AU2011290126A1 (en) 2013-03-07
WO2012020848A8 (en) 2012-09-27
US20190263832A1 (en) 2019-08-29
KR20130138738A (ko) 2013-12-19
EA201390222A1 (ru) 2013-08-30
AU2011290126B2 (en) 2016-01-07
US20180162875A1 (en) 2018-06-14
US20120077799A1 (en) 2012-03-29
CA2807460C (en) 2018-09-18
TW201217386A (en) 2012-05-01
PT2603513T (pt) 2020-06-08
MX2013001614A (es) 2013-07-05
US9884875B2 (en) 2018-02-06
MA34509B1 (fr) 2013-09-02
US11279713B2 (en) 2022-03-22

Similar Documents

Publication Publication Date Title
HRP20200844T1 (hr) Heterociklički spoj i njegova uporaba kao pozitivnog alosteričnog modulatora ampa-receptora
Dawood An update on benzofuran inhibitors: a patent review
Artigas Serotonin receptors involved in antidepressant effects
DOP2015000069A (es) Piridinonas bicíclicas novedosas
MY156530A (en) Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
NZ741907A (en) 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
JP2015514677A5 (enExample)
PH12013500007A1 (en) Piperidine derivatives and their use for the treatment of metabolic disorders
AR093408A1 (es) Derivados de oxazolidin-2-ona-pirimidina
WO2014151393A3 (en) Carboxamide derivatives and use thereof
MD4371B1 (ro) Derivaţi de benzo¢f]¢1,4]oxazepin-5-one ca modulatori ai canalelor ionice
MX2015008090A (es) Compuestos de piridina-2-carboxamida sustituida como inhibidores de cinasa reguladora de señal de apoptosis.
EA201390381A1 (ru) Триазиноксадиазолы
JP2014523851A5 (enExample)
EA201791271A1 (ru) ТИАЗОЛЫ, ЗАМЕЩЕННЫЕ КАРБОКСАМИДОМ ИЛИ СУЛЬФОНАМИДОМ, И РОДСТВЕННЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ ДЛЯ ОРФАННОГО ЯДЕРНОГО РЕЦЕПТОРА RORγ
PH12014502363A1 (en) N-aryltriazole compounds as lpar antagonists
PH12014502789A1 (en) N-alkyltriazole compounds as lpar antagonists
MX359988B (es) Derivado de pirazol y uso del mismo para propósitos médicos.
BR112015004499A2 (pt) métodos de administração de terapia de pirfenidona
EA201490630A1 (ru) 6-замещенные 3-(хинолин-6-илтио)[1,2,4]триазоло[4,3-a]пиридины в качестве ингибиторов c-met тирозинкиназы
EP2643002A4 (en) PHARMACEUTICAL FORMULATIONS WITH CORTICOSTEROIDS FOR TOPICAL ADMINISTRATION
WO2012099952A3 (en) Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
NZ611529A (en) Glucagon receptor modulators
Pei et al. Controlled synthesis of 2-and 3-substituted benzo [b] furans
ES2887011T3 (es) Derivados de isotiazol como agonistas de GPR120 para el tratamiento de diabetes de tipo II